logo

For the Inventor, By the Inventor

Cachan, France

Gihad Dargazanli

This inventor holds 16 USPTO granted patents and 3 published patent applications. Top assignees: Sanofi-Aventis, Sanofi, Synthelabo. Active years: 1999-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gihad Dargazanli. Retrieved from https://idiyas.com/inventor/gihad-dargazanli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 31.3

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • L'Hay les Roses, FR (1999)
  • Paris, FR (2010)
  • Cachan, FR (2006 - 2013)

Company Filing History:

goldMedal14 out of 390 
 
Sanofi-Aventis
 patents
silverMedal1 out of 1,546 
 
Sanofi
 patents
bronzeMedal1 out of 252 
 
Synthelabo
 patents

Years Active: 1999-2013

Loading Chart...
16 patents (USPTO):Explore Patents
1. 8513246 - [object Object] (2013-08-20),
2. 8119687 - Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics (2012-02-21),
3. 7951821 - N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy (2011-05-31),
4. 7790753 - Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics (2010-09-07),
5. 7777057 - Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics (2010-08-17),
6. 7776880 - Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof (2010-08-17),
7. 7750025 - Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics (2010-07-06),
8. 7700585 - Derivatives of N-[phenyl(pyrrolidine-2-YL)methyl]benzamide and N-[(azepan-2-YL) phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics (2010-04-20),
9. 7619089 - [object Object] (2009-11-17),
10. 7335670 - Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics (2008-02-26),
11. 7326722 - N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy (2008-02-05),
12. 7288656 - Derivatives of N-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics (2007-10-30),
13. 7226917 - Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation, and use in treatment of schizophrenia (2007-06-05),
14. 7205319 - N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy (2007-04-17),
15. 7119116 - Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics (2006-10-10),

Title: Gihad Dargazanli: Innovator in Therapeutic Compositions

Introduction

Gihad Dargazanli is a prominent inventor based in Cachan, France. He has made significant contributions to the field of therapeutics, holding a total of 16 patents. His work focuses on innovative compositions that have the potential to treat a variety of diseases.

Latest Patents

Dargazanli's latest patents include inventions related to the use of compositions in therapeutics. One notable invention involves a compound with a general formula that includes various substituents, such as phenyl or naphthalenyl groups. These compounds are designed for therapeutic applications, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Gihad Dargazanli has worked with notable companies, including Sanofi-Aventis and Synthelabo. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Dargazanli has collaborated with several professionals in his field, including Genevieve Estenne-Bouhtou and Florence Medaisko. These partnerships have contributed to the success of his inventions and the advancement of therapeutic compositions.

Conclusion

Gihad Dargazanli is a distinguished inventor whose work in therapeutics has led to numerous patents and collaborations. His innovative contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…